-
Maximising Returns from Life Science Innovation: Genesis Conference 2024
London, United Kingdom, 29th November 2024 / One Nucleus The 24th Life Science networking conference, organised by membership organisation One Nucleus, will be hosted at the Royal Society of Medicine, on Wednesday 4th December. In a ‘first’ this year, Genesis is being co-located with Life Science Nation’s annual ‘Redefining Early-Stage Investments’ conference, connecting companies developing drugs, devices, digital…
-
SynbiCITE awarded £3m EPSRC grant to expand engineering biology proof-of-concept programme
Imperial College, London, 14th November 2024 / SynbiCITE, the U.K.’s National Industrial Translation Centre for Engineering Biology, has been awarded a grant of £3m to expand its Proof-of-Concept (PoC) programme for start-up engineering biology companies. The new programme comprises three stages: i) an ideation and basic PoC stage, ii) a six-month extension project which will…
-
2BScientific Limited announces opening of a new European hub in Germany
Kirtlington, Oxfordshire, UK / 14th November 2024 / 2BScientific Limited proudly announces the opening of its first European hub in Munich, Germany, establishing a strong base to service the growing European markets. The hub will also enable the company to enter new supplier partnerships, enhancing the range of products available to its European customers and…
-
Rousselot and IamFluidics Launch Revolutionary Dissolvable Microcarrier for Scalable Cell Culturing
Irving, Texas, 12th November 2024 – Rousselot, Darling Ingredients’ premier collagen and gelatin brand, and IamFluidics, a leader in microparticle innovation, today announced the launch of a novel research grade dissolvable microcarrier for adherent cell culturing. The product is designed to streamline and scale-up processes for advanced cell therapies, biologics manufacturing and cultured meat production. …
-
MultiOmic Health announces discovery of novel endotypes and biomarkers for diabetic kidney disease
London, UK, 12th November 2024 / MultiOmic Health, a leading AI-enabled drug discovery company, announces the identification of novel patient endotypes and the development of proprietary biomarkers for stratifying diabetic kidney disease (DKD) patients. This breakthrough enables precise segmentation of DKD patients by disease trajectory over time, marking a pivotal advancement in precision medicine for…
-
Nuclera’s eProtein Discovery system installed at Domainex to streamline protein production services
Cambridge, UK, 04 November 2024 / Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery™ system, and Domainex, a multi-award winning provider of integrated, pre-clinical drug discovery services, today announced that Domainex is the first contract research organization (CRO) to have installed the eProtein Discovery system and offer protein production…
-
Domainex included in inaugural special report from the Financial Times recognising Europe’s Long-Term Growth Champions
Cambridge, UK, 30th October 2024 / Domainex, a multi-award winning, leading provider of drug discovery services, is proud to announce its inclusion in the very first edition of the Financial Times ‘Europe’s Long-Term Growth Champions’ special report compiled in partnership with Statista. This study aimed to identify and highlight European enterprises with long-term sustained organic growth. The 300 companies included…
-
Watson-Marlow Fluid Technology Solutions to showcase peristaltic filling machines and new single-use solutions at PACK EXPO International 2024
Devens, MA, USA, 23rd October 2024 / Sciad Communications / Watson-Marlow Fluid Technology Solutions (WMFTS) will display a range of peristaltic pumps and associated fluid path technologies designed for the life sciences sector during PACK EXPO International 2024 from November 3-6. WMFTS will be at booth 14101 in the West Hall (Healthcare Packaging Pavilion), where…
-
Watson-Marlow Fluid Technology Solutions showcases peristaltic filling machines and single-use solutions at the 2024 ISPE Annual Meeting and Expo
Devens, MA, USA, 7th October 2024 / Sciad Communications / Watson-Marlow Fluid Technology Solutions (WMFTS) will display a range of peristaltic pumps and associated fluid path technologies designed for the pharmaceutical industry during the 2024 ISPE Annual Meeting & Expo from October 13-16. Located at booth 1513, WMFTS will demonstrate its new range of single-use…
-
Rousselot and xolo Strengthen Collaboration in 3D Bioprinting Research with Co-Branding Agreement
Irving, Texas, USA, 26th September 2024 / Rousselot, Darling Ingredients’ premier collagen and gelatin brand, and xolo, a German company specializing in 3D printing for research and medical applications, today announced a co-branding agreement. This collaboration integrates Rousselot’s X-Pure® GelMA solution into xolo’s ready-to-use bioinks for volumetric 3D printers. xolo, known for its high-performance bioprinters, uses its…